Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Sinew Pharma Inc.

Clinical trials sponsored by Sinew Pharma Inc., explained in plain language.

Not yet recruiting 1

New pill aims to fight dangerous liver fat buildup

Disease control Not yet recruiting

This study is testing whether a new oral medication called SNP-610 can help people with non-alcoholic steatohepatitis (NASH), a serious form of fatty liver disease. About 80 participants in Taiwan will take either the drug or a placebo pill daily for 3 months to see if it reduces…

Phase: PHASE2 • Sponsor: Sinew Pharma Inc. • Aim: Disease control

Last updated Apr 04, 2026 11:20 UTC